<em>A & E</em>
Further explanation
Recombinant proteins such as vaccines, antibodies, hormones, and medicines are increasingly needed by livestock and humans. The main obstacle to producing recombinant proteins in Escherichia coli as the most widely used host is degradation by proteolytic enzymes. This is because E. coli has a number of proteolytic enzymes that are spread in the cytoplasm. For this reason, more than 90% of protein degradation occurs in the cytoplasm. In this study, researchers have produced mutants E. coli BW25113 that do not have a protease enzyme coding gene using a combination of chromosome destruction and phage P1 transduction methods. The making of the mutant begins with the destruction of the protease enzyme coding gene on the bacterial chromosome with a PCR product which has a homologous portion with the target gene. The mutants produced are then used to produce double mutants using the Phage P1 Transduction method. Phenotive and genotive analysis shows that the combination of the two methods is very effective for making more than one mutation in E. coli. For this reason, E. coli mutants that have been obtained will be very useful to produce various recombinant proteins for livestock and humans.
Beta-galactosidase or β-galactosidase is one of the hydrolase enzymes included in the fig operon whose function is to accelerate the conversion reaction from galactosides to galactose, such as lactose to monosaccharides namely galactose and glucose.
These enzyme substrates include GM1 gangliosides, lactosylceramides, lactose, and various glycoproteins. [Citation needed]
This enzyme is coded by lacZ and has an isomer called α-galactosidase (melibiase).
In humans, this glycoprotein has a length of 677 AA, encoded in the GLB1 or ELNR1 gene and has 2 isomers that live in the perinuclear cytoplasm and lysosomes
Learn More
Beta-galactosidase : brainly.com/question/11758698
Details
Class: high school
Subject: biology
Keywords : galactosidase, enzyme, e. coli, mutans